colon cancer

Epigenetic Drugs Reset Genes in Breast, Colon Cancers But Didn’t Shrink Tumors

Posted by  | Research, treatment

--Two clinical trials suggest promise for using these medications in combination with other cancer therapies Two clinical trials using combinations of drugs meant to change cancer epigentics —or the way tumors express genes — failed at shrinking colon and breast tumors. However, these trials open the door for others currently in the works to combine(...)

Cancer News Review

Posted by  | Research

Cancer headlines this past month included two studies on colonoscopy, a screening tool for colon cancer.  The first study looks at the long-term benefits of colonoscopy and found that 50 percent of colon cancer cases were avoided by a single colonscopy.  In the Cancer News Review podcast, William Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer(...)

Cancer Screening Tests Everyone Should Know

Posted by  | Issues & Perspectives, Prevention/Screening

Kimmel Cancer experts frequently say that “the best way to cure cancer is to prevent it from ever occurring.”  Most experts agree that currently-available cancer screening tests have lead to a decline in cancer deaths.  Moreover, they allow cancers to be detected early, making more treatment options available to patients. Let me say up front,(...)

What’s Your Colon Cancer IQ?

Posted by  | Uncategorized

March is colon cancer awareness month. How much do you know about protecting yourself against colon cancer? As Dr. Luis Diaz of the Kimmel Cancer Center says, “No one should die from this disease.” Yet, colon cancer is the 3rd most common cancer diagnosed in both men and women in the US, and the 2nd leading(...)

A Prize, Promotion and Press Story

Posted by  | Issues & Perspectives, Research

About ten years ago, researcher Bert Vogelstein appeared with Katie Couric on the Today Show to announce new research on a stool test for colon cancer.  Since then, he's mapped scores of cancer genomes to boost knowledge about cancer-related genes, and the Brupbacher Foundation in Zurich has now awarded Vogelstein a prize for his research(...)